122 related articles for article (PubMed ID: 17510533)
1. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.
Hagiwara K; Nagai H; Li Y; Ohashi H; Hotta T; Saito H
J Clin Exp Hematop; 2007 Apr; 47(1):15-8. PubMed ID: 17510533
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS
Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.
Sharma P; Chinaranagari S; Patel D; Carey J; Chaudhary J
Cancer Med; 2012 Oct; 1(2):176-86. PubMed ID: 23342267
[TBL] [Abstract][Full Text] [Related]
5. ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
Ushmorov A; Leithäuser F; Ritz O; Barth TF; Möller P; Wirth T
Leukemia; 2008 Oct; 22(10):1942-4. PubMed ID: 18368067
[No Abstract] [Full Text] [Related]
6. [Methylation of Id4 gene promoter in 4 malignant hematopoietic cell lines].
Zhao Y; Wang QS; Li HH; Jing Y; Bo J; Wang SH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1418-20. PubMed ID: 19099656
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
[TBL] [Abstract][Full Text] [Related]
9. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
[TBL] [Abstract][Full Text] [Related]
13. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL.
Chen SS; Claus R; Lucas DM; Yu L; Qian J; Ruppert AS; West DA; Williams KE; Johnson AJ; Sablitzky F; Plass C; Byrd JC
Blood; 2011 Jan; 117(3):862-71. PubMed ID: 21098398
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype.
Li Y; Nagai H; Ohno T; Yuge M; Hatano S; Ito E; Mori N; Saito H; Kinoshita T
Blood; 2002 Oct; 100(7):2572-7. PubMed ID: 12239171
[TBL] [Abstract][Full Text] [Related]
16. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
17. [Significance of id4 gene promoter methylation detection in lymphoma].
Zhao Y; Jing Y; Bo J; Wang SH; Wang QS; Li HH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):322-4. PubMed ID: 18426657
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
Sharma P; Chinaranagari S; Chaudhary J
Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
[TBL] [Abstract][Full Text] [Related]
19. The many layers of epigenetic dysfunction in B-cell lymphomas.
Jiang Y; Dominguez PM; Melnick AM
Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
[TBL] [Abstract][Full Text] [Related]
20. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]